Acesso livre
Acesso livre

Oncologia

Causas do câncer hepático estão mudando ao redor do mundo: algumas ganham força, outras perdem.

19 Jun, 2022 | 13:17h

Comunicado de imprensa: Causes of Liver Cancer are Changing Around the World: Some Up, Some Down – UC San Diego Health

Estudo original: Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer – Cell Metabolism (link para o resumo – $ para o texto completo)


Revisão sistemática | Oxicodona para dor relacionada a câncer.

19 Jun, 2022 | 13:05h

Oxycodone for cancer‐related pain – Cochrane Library

Resumo: Oxycodone for cancer-related pain in adults – Cochrane Library


DNA circulante de tumor e recorrência tardia em câncer de mama de alto risco, positivo para receptor de hormônio e negativo para receptor do fator de crescimento epidérmico humano 2.

19 Jun, 2022 | 13:04h

Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer – Journal of Clinical Oncology

Editorial: Can a Late Interception by Circulating Tumor DNA Deliver a Win in Estrogen Receptor–Positive Early Breast Cancer?

Comentário: Tumor DNA Assay Portends Metastatic Breast Cancer Recurrence Months in Advance — First evidence for patients in late adjuvant setting, years after initial diagnosis – MedPage Today (necessário cadastro gratuito)

 

Comentário no Twitter

 


Estudo de coorte retrospectiva | Incidência de eventos cardíacos adversos maiores com imunoterápicos.

19 Jun, 2022 | 13:00h

Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute—Cancer Therapy Evaluation Program – Journal of Clinical Oncology

Conteúdos relacionados:

Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment – Journal of the American Heart Association

Cardiotoxicity of immune checkpoint inhibitors – ESMO Open

Cardiotoxicity from immune checkpoint inhibitors – IJC Heart & Vasculature

Cardiovascular toxicity of immune checkpoint inhibitors in cancer patients: A review when cardiology meets immuno-oncology – Journal of the Formosan Medical Association

Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock – JACC: CardioOncology


Resultados de longo prazo de estudo randomizado | Radioterapia prostática para homens com câncer de próstata metastático.

16 Jun, 2022 | 13:37h

Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial – PLOS Medicine


Novo estudo associa a ingestão de laticínios com maior risco de câncer de próstata.

16 Jun, 2022 | 13:29h

Comunicado de imprensa: New study associates intake of dairy milk with greater risk of prostate cancer – Loma Linda University Adventist Health Sciences Center

Estudo original: Dairy foods, calcium intakes, and risk of incident prostate cancer in Adventist Health Study–2 – American Journal of Clinical Nutrition (link para o resumo – $ para o texto completo)


M-A | Prevalência de depressão entre cuidadores de pacientes oncológicos.

16 Jun, 2022 | 13:19h

Systematic Review and Meta-Analysis of Prevalence of Depression Among Caregivers of Cancer Patients – Frontiers in Psychiatry


Revisão sistemática | Inteligência artificial e algoritmos de aprendizado de máquina (machine learning) para detecção precoce de câncer de pele na comunidade e em ambientes de atenção primária.

16 Jun, 2022 | 13:16h

Artificial intelligence and machine learning algorithms for early detection of skin cancer in community and primary care settings: a systematic review – The Lancet Digital Health

 

Comentário no Twitter

 


Revisão | Retirada de medicamentos no cuidado paliativo oncológico.

16 Jun, 2022 | 13:07h

Deprescribing in Palliative Cancer Care – Life


Estudo confirma que o rastreamento a cada 5 anos é seguro para mulheres com teste negativo para HPV.

16 Jun, 2022 | 13:06h

Comunicado de imprensa: Screening every five years safe for women who test negative for HPV, study confirms – King’s College London

Estudo original: Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data – The BMJ

Editorial: HPV screening for cervical cancer is reaching maturity – The BMJ

Diretriz OMS relacionada:

Comunicado de imprensa: New recommendations for screening and treatment to prevent cervical cancer – World Health Organization

Ver diretriz: WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention – World Health Organization

Diretriz USPSTF relacionada: Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement – JAMA


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.